Improved Antitumor Activity of a Therapeutic Melanoma Vaccine through the Use of the Dual COX-2/5-LO Inhibitor Licofelone.

Front Immunol · 2016 · PMC5137024 · PMID 27994586

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Examination of myeloid subsets in the td-LNs showed a trend toward a reduced frequency of Gr-1 + CD11b + IMCs in mice treated with any of the three formulations; however, this was not significant.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.